U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C28H26N2O5
Molecular Weight 470.5164
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of IMIGLITAZAR

SMILES

CC1=C(COC2=CC=C(CO\N=C(/CCC(O)=O)C3=CC=CC=C3)C=C2)N=C(O1)C4=CC=CC=C4

InChI

InChIKey=ULVDFHLHKNJICZ-QCWLDUFUSA-N
InChI=1S/C28H26N2O5/c1-20-26(29-28(35-20)23-10-6-3-7-11-23)19-33-24-14-12-21(13-15-24)18-34-30-25(16-17-27(31)32)22-8-4-2-5-9-22/h2-15H,16-19H2,1H3,(H,31,32)/b30-25+

HIDE SMILES / InChI

Molecular Formula C28H26N2O5
Molecular Weight 470.5164
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Imiglitazar (also known as TAK-559) is a dual peroxisome proliferator-activated receptor (PPAR) alpha and gamma agonist patented by Japanese pharmaceutical company Takeda Chemical Industries for the prevention or treatment of diabetes mellitus, hyperlipemia, insulin insensitivity, insulin resistance, and impaired glucose tolerance. Imiglitazar shows potent hypoglycemic and hypolipidemic activity and has been studied in clinical trials in treating subjects receiving a stable dose of insulin to control type 2 diabetes mellitus. Unfortunately, Imiglitazar shows hepatotoxicity and has never been marketed.

Approval Year

PubMed

PubMed

TitleDatePubMed
Medicinal Chemistry and Actions of Dual and Pan PPAR Modulators.
2011
Patents

Sample Use Guides

TAK-559 32 mg, tablets, orally, once daily and insulin stable dose injection for up to 54 weeks.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Wed Apr 02 09:16:49 GMT 2025
Edited
by admin
on Wed Apr 02 09:16:49 GMT 2025
Record UNII
7244710F59
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
IMIGLITAZAR
INN  
INN  
Official Name English
TAK-559
Preferred Name English
imiglitazar [INN]
Common Name English
(E)-4-(((4-((5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)METHOXY)PHENYL)METHOXY)IMINO)-4-PHENYLBUTANOIC ACID
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C98233
Created by admin on Wed Apr 02 09:16:49 GMT 2025 , Edited by admin on Wed Apr 02 09:16:49 GMT 2025
Code System Code Type Description
SMS_ID
300000034214
Created by admin on Wed Apr 02 09:16:49 GMT 2025 , Edited by admin on Wed Apr 02 09:16:49 GMT 2025
PRIMARY
ChEMBL
CHEMBL592054
Created by admin on Wed Apr 02 09:16:49 GMT 2025 , Edited by admin on Wed Apr 02 09:16:49 GMT 2025
PRIMARY
EPA CompTox
DTXSID00870280
Created by admin on Wed Apr 02 09:16:49 GMT 2025 , Edited by admin on Wed Apr 02 09:16:49 GMT 2025
PRIMARY
DRUG BANK
DB12511
Created by admin on Wed Apr 02 09:16:49 GMT 2025 , Edited by admin on Wed Apr 02 09:16:49 GMT 2025
PRIMARY
INN
8460
Created by admin on Wed Apr 02 09:16:49 GMT 2025 , Edited by admin on Wed Apr 02 09:16:49 GMT 2025
PRIMARY
PUBCHEM
9890879
Created by admin on Wed Apr 02 09:16:49 GMT 2025 , Edited by admin on Wed Apr 02 09:16:49 GMT 2025
PRIMARY
FDA UNII
7244710F59
Created by admin on Wed Apr 02 09:16:49 GMT 2025 , Edited by admin on Wed Apr 02 09:16:49 GMT 2025
PRIMARY
NCI_THESAURUS
C83791
Created by admin on Wed Apr 02 09:16:49 GMT 2025 , Edited by admin on Wed Apr 02 09:16:49 GMT 2025
PRIMARY
CAS
250601-04-8
Created by admin on Wed Apr 02 09:16:49 GMT 2025 , Edited by admin on Wed Apr 02 09:16:49 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> AGONIST
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY